glp-1/gip dual agonist The Emerging Role of GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Mechanisms of action of GLP-1

Artificial intelligence can support target identification, clinical trial design, biomarker discovery, patient stratification, real-world evidence generation, and safety monitoring

Moringa's isothiocyanates inhibit alpha-glucosidase and alpha-amylase- the enzymes that break complex carbohydrates into glucose in your digestive tract

Hair loss during GLP-1 therapy is real

As obesity rates rise and trust in GLP-1R products grows, sales for drugs targeting this receptor are forecast to increase fourfold to an estimated $142 billion by 2030

Some studies suggest a meaningful percentage of total weight loss may come from lean mass